SCHEMBL18006706

SCHEMBL18006706

CN(C)Cc1cc(Cl)cc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.47
TSHR P16473 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HRH3 Q9Y5N1 2/20 0.44
MAPT P10636 2/20 0.43
GAA P10253 2/20 0.43
LMNA P02545 1/20 0.43
GSR P00390 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TACR1 P25103 1/20 0.42
POLB P06746 2/20 0.42
IDO1 P14902 2/20 0.41
NOS1 P29475 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
G6PD P11413 1/20 0.37
PABPC1 P11940 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24636832 0.86 TAAR1 (0.42) TAAR1TSHRALDH1A1HRH3MAPT
SCHEMBL625806 0.84 PNMT (0.42) TAAR1TSHRALDH1A1HRH3MAPT
SCHEMBL2528801 0.80 ALDH1A1 (0.55) TAAR1TSHRALDH1A1HRH3MAPT
SCHEMBL3464118 0.78 TAAR1 (0.60) TAAR1TSHRALDH1A1HRH3TACR1
SCHEMBL14585683 0.77 IDO1 (0.40) TAAR1TSHRALDH1A1MAPTTACR1
SCHEMBL8290710 0.77 TAAR1 (0.66) TAAR1TSHRALDH1A1GAAPOLB
SCHEMBL30798978 0.77 TAAR1 (0.66) TAAR1TSHRALDH1A1GAAPOLB
SCHEMBL13032565 0.75 SLC6A4 (0.42) TAAR1TSHRALDH1A1HRH3MAPT
SCHEMBL6121488 0.75 ALDH1A1 (0.41) TAAR1TSHRALDH1A1HRH3MAPT
SCHEMBL21674175 0.75 SIGMAR1 (0.39) TAAR1TSHRALDH1A1MAPTTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253548-A1 SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2021-08-19 US disclosed
WO-2016132134-A1 THIAZOLE DERIVATIVES FOR THE TREATMENT OF ANIMAL TRYPANOSOMIASIS UNIVERSITY OF DUNDEE (GB) 2016-08-25 WO disclosed
WO-2016132134-A1 THIAZOLE DERIVATIVES FOR THE TREATMENT OF ANIMAL TRYPANOSOMIASIS UNIVERSITY OF DUNDEE (GB) 2016-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253548-A1 SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF RDX, RRM1, BRIX1 TAAR1 2628/4885TSHR 430/4885ALDH1A1 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.